compound introduction
Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor. Gln-AMS inhibits glutaminyl-tRNA synthetase (GlnRS) with a K i of 1.32 µM. Appearance:Solid IC50& Target:Ki: 1.32 µM (GlnRS) In Vitro:Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Biological Activity:Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor. Gln-AMS inhibits glutaminyl-tRNA synthetase (GlnRS) with a K i of 1.32 µM.
